These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25872148)

  • 1. Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer.
    Belardinilli F; Capalbo C; Buffone A; Petroni M; Colicchia V; Ferraro S; Zani M; Nicolussi A; D'Inzeo S; Coppa A; Screpanti I; Gulino A; Giannini G
    Clin Biochem; 2015 Sep; 48(13-14):908-10. PubMed ID: 25872148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients.
    Malapelle U; Vigliar E; Sgariglia R; Bellevicine C; Colarossi L; Vitale D; Pallante P; Troncone G
    J Clin Pathol; 2015 Jan; 68(1):64-8. PubMed ID: 25378536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of different massive parallel sequencing platforms for mutation profiling in formalin-fixed and paraffin-embedded samples].
    Jiang RR; Wang YJ; Teng XD; Xiao L; Bu H; Ye F
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):591-596. PubMed ID: 30107663
    [No Abstract]   [Full Text] [Related]  

  • 4. Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR.
    Gao J; Wu H; Wang L; Zhang H; Duan H; Lu J; Liang Z
    BMJ Open; 2016 Jan; 6(1):e009532. PubMed ID: 26747035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung Cancer.
    Fujita S; Masago K; Takeshita J; Okuda C; Otsuka K; Hata A; Kaji R; Katakami N; Hirata Y
    PLoS One; 2015; 10(6):e0130219. PubMed ID: 26076009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of variations and identifying genomic breakpoints for large deletions in the LDLR by Ion Torrent semiconductor sequencing.
    Faiz F; Allcock RJ; Hooper AJ; van Bockxmeer FM
    Atherosclerosis; 2013 Oct; 230(2):249-55. PubMed ID: 24075752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of the Ion Torrent PGM next generation sequencing for analysis of the most commonly mutated genes among patients with colorectal cancer in India.
    Mehra S; Tiwari AK; Mehta SP; Sachdev R; Rajvanshi C; Chauhan R; Saini A; Vaid A
    Indian J Cancer; 2022; 59(2):218-222. PubMed ID: 33753628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for genetic mutations in hyperphenylalaninemia using Ion Torrent PGM sequencing].
    Cao Y; Qu Y; Song F; Bai J; Jin Y; Wang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Feb; 32(1):16-20. PubMed ID: 25636092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study.
    Udar N; Lofton-Day C; Dong J; Vavrek D; Jung AS; Meier K; Iyer A; Slaughter R; Gutekunst K; Bach BA; Peeters M; Douillard JY
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2001-2010. PubMed ID: 30019318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in
    Hwang SM; Lee KC; Lee MS; Park KU
    Cancer Res Treat; 2018 Jan; 50(1):255-264. PubMed ID: 28392550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast clinical molecular diagnosis of hyperphenylalaninemia using next-generation sequencing-based on a custom AmpliSeq™ panel and Ion Torrent PGM sequencing.
    Cao YY; Qu YJ; Song F; Zhang T; Bai JL; Jin YW; Wang H
    Mol Genet Metab; 2014 Dec; 113(4):261-6. PubMed ID: 25456745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences.
    Normanno N; Pinto C; Castiglione F; Fenizia F; Barberis M; Marchetti A; Fontanini G; De Rosa G; Taddei GL
    J Transl Med; 2015 Sep; 13():287. PubMed ID: 26335936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of pyrosequencing methods for the rapid detection of RAS mutations in clinical samples.
    Cortes U; Guilloteau K; Rouvreau M; Archaimbault C; Villalva C; Karayan-Tapon L
    Exp Mol Pathol; 2015 Oct; 99(2):207-11. PubMed ID: 26163758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnostics of the HBB gene in an Omani cohort using bench-top DNA Ion Torrent PGM technology.
    Hassan SM; Vossen RH; Chessa R; den Dunnen JT; Bakker E; Giordano PC; Harteveld CL
    Blood Cells Mol Dis; 2014 Sep; 53(3):133-7. PubMed ID: 24880717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
    Sakai K; Tsurutani J; Yamanaka T; Yoneshige A; Ito A; Togashi Y; De Velasco MA; Terashima M; Fujita Y; Tomida S; Tamura T; Nakagawa K; Nishio K
    PLoS One; 2015; 10(5):e0121891. PubMed ID: 25954997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratory.
    Mehrotra M; Duose DY; Singh RR; Barkoh BA; Manekia J; Harmon MA; Patel KP; Routbort MJ; Medeiros LJ; Wistuba II; Luthra R
    PLoS One; 2017; 12(8):e0181968. PubMed ID: 28767674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare RAS Mutations in Metastatic Colorectal Cancer Detected During Routine RAS Genotyping Using Next Generation Sequencing.
    Harlé A; Filhine-Tresarrieu P; Husson M; Boidot R; Rouyer M; Dubois C; Leroux A; Merlin JL
    Target Oncol; 2016 Jun; 11(3):363-70. PubMed ID: 26661077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening of extended RAS mutations based on high-resolution melting analysis for prediction of anti-EGFR treatment efficacy in colorectal carcinoma.
    Ishige T; Itoga S; Sato K; Kitamura K; Nishimura M; Sawai S; Matsushita K; Suzuki K; Ota S; Miyauchi H; Matsubara H; Nakatani Y; Nomura F
    Clin Biochem; 2014 Dec; 47(18):340-3. PubMed ID: 25262986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.
    Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R
    J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
    Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
    Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.